- Home
- CCIR vs ORIC Comparison
CCIR vs ORIC Comparison
Compare CCIR & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIR
- ORIC
- Stock Information
- Founded
- CCIR 2021
- ORIC 2014
- Country
- CCIR United States
- ORIC United States
- Employees
- CCIR N/A
- ORIC N/A
- Industry
- CCIR
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- CCIR
- ORIC Health Care
- Exchange
- CCIR NYSE
- ORIC Nasdaq
- Market Cap
- CCIR 370.0M
- ORIC 362.9M
- IPO Year
- CCIR 2024
- ORIC 2020
- Fundamental
- Price
- CCIR $12.95
- ORIC $5.31
- Analyst Decision
- CCIR
- ORIC Strong Buy
- Analyst Count
- CCIR 0
- ORIC 8
- Target Price
- CCIR N/A
- ORIC $18.83
- AVG Volume (30 Days)
- CCIR 205.4K
- ORIC 583.2K
- Earning Date
- CCIR 01-01-0001
- ORIC 05-05-2025
- Dividend Yield
- CCIR N/A
- ORIC N/A
- EPS Growth
- CCIR N/A
- ORIC N/A
- EPS
- CCIR 0.16
- ORIC N/A
- Revenue
- CCIR N/A
- ORIC N/A
- Revenue This Year
- CCIR N/A
- ORIC N/A
- Revenue Next Year
- CCIR N/A
- ORIC N/A
- P/E Ratio
- CCIR $77.23
- ORIC N/A
- Revenue Growth
- CCIR N/A
- ORIC N/A
- 52 Week Low
- CCIR $9.92
- ORIC $3.90
- 52 Week High
- CCIR $12.80
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- CCIR N/A
- ORIC 48.02
- Support Level
- CCIR N/A
- ORIC $4.52
- Resistance Level
- CCIR N/A
- ORIC $5.59
- Average True Range (ATR)
- CCIR 0.00
- ORIC 0.49
- MACD
- CCIR 0.00
- ORIC 0.07
- Stochastic Oscillator
- CCIR 0.00
- ORIC 57.25
About CCIR COHEN CIRCLE ACQUISITION CORP I
Cohen Circle Acquisition Corp I is a blank check company.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.